Stephanie E. Kong

1.9k total citations
15 papers, 1.6k citations indexed

About

Stephanie E. Kong is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Stephanie E. Kong has authored 15 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Stephanie E. Kong's work include Genomics and Chromatin Dynamics (6 papers), RNA Research and Splicing (5 papers) and DNA Repair Mechanisms (4 papers). Stephanie E. Kong is often cited by papers focused on Genomics and Chromatin Dynamics (6 papers), RNA Research and Splicing (5 papers) and DNA Repair Mechanisms (4 papers). Stephanie E. Kong collaborates with scholars based in United States, United Kingdom and Japan. Stephanie E. Kong's co-authors include Ronald Conaway, Joan Conaway, Charles A.S. Banks, Michael P. Washburn, Laurence Florens, Selene K. Swanson, Ali Shilatifard, Jingji Jin, Andreas G. Ladurner and Yong Cai and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stephanie E. Kong

15 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephanie E. Kong United States 14 1.3k 296 180 166 114 15 1.6k
Wesley Hung Canada 20 829 0.6× 162 0.5× 295 1.6× 67 0.4× 182 1.6× 30 1.4k
Taichi Uetsuki Japan 19 1.1k 0.8× 119 0.4× 220 1.2× 409 2.5× 143 1.3× 25 1.5k
Vincent Ossipow Switzerland 12 619 0.5× 93 0.3× 96 0.5× 114 0.7× 56 0.5× 14 993
Juliet Reid United Kingdom 13 1.6k 1.2× 597 2.0× 92 0.5× 272 1.6× 121 1.1× 13 2.0k
Carolyn H. Michnoff United States 13 831 0.6× 118 0.4× 82 0.5× 104 0.6× 141 1.2× 14 1.2k
Peri Tate United Kingdom 16 1.9k 1.5× 137 0.5× 112 0.6× 728 4.4× 238 2.1× 21 2.3k
Akiko Yanagiya Canada 19 1.1k 0.8× 69 0.2× 126 0.7× 116 0.7× 67 0.6× 31 1.5k
Alison L. Clayton United Kingdom 16 2.3k 1.8× 211 0.7× 87 0.5× 283 1.7× 103 0.9× 18 2.7k
Ira Schieren United States 21 1.0k 0.8× 451 1.5× 232 1.3× 101 0.6× 213 1.9× 32 1.6k
Galit Shohat-Ophir Israel 17 949 0.7× 117 0.4× 347 1.9× 169 1.0× 264 2.3× 32 1.6k

Countries citing papers authored by Stephanie E. Kong

Since Specialization
Citations

This map shows the geographic impact of Stephanie E. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie E. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie E. Kong more than expected).

Fields of papers citing papers by Stephanie E. Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie E. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie E. Kong. The network helps show where Stephanie E. Kong may publish in the future.

Co-authorship network of co-authors of Stephanie E. Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie E. Kong. A scholar is included among the top collaborators of Stephanie E. Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie E. Kong. Stephanie E. Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liu, Rong, Stephanie Curry, Patricia McMonagle, et al.. (2015). Susceptibilities of Genotype 1a, 1b, and 3 Hepatitis C Virus Variants to the NS5A Inhibitor Elbasvir. Antimicrobial Agents and Chemotherapy. 59(11). 6922–6929. 59 indexed citations
2.
Banks, Charles A.S., Stephanie E. Kong, & Michael P. Washburn. (2012). Affinity purification of protein complexes for analysis by multidimensional protein identification technology. Protein Expression and Purification. 86(2). 105–119. 21 indexed citations
3.
Takahashi, Hidehisa, Tari Parmely, Shigeo Sato, et al.. (2011). Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors. Cell. 146(1). 92–104. 264 indexed citations
4.
Cochran, Jared C., Charles V. Sindelar, Kimberly A. Collins, et al.. (2009). ATPase Cycle of the Nonmotile Kinesin NOD Allows Microtubule End Tracking and Drives Chromosome Movement. Cell. 136(1). 110–122. 52 indexed citations
5.
Aygün, Ozan, Xiaohua Xu, Yilun Liu, et al.. (2009). Direct Inhibition of RNA Polymerase II Transcription by RECQL5. Journal of Biological Chemistry. 284(35). 23197–23203. 56 indexed citations
6.
Gottschalk, Aaron J., Gyula Timinszky, Stephanie E. Kong, et al.. (2009). Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proceedings of the National Academy of Sciences. 106(33). 13770–13774. 288 indexed citations
7.
Harreman, Michelle T., Michael Täschner, Stefán Sigurðsson, et al.. (2009). Distinct ubiquitin ligases act sequentially for RNA polymerase II polyubiquitylation. Proceedings of the National Academy of Sciences. 106(49). 20705–20710. 140 indexed citations
8.
Hikida, Takatoshi, Hanna Jaaro-Peled, Saurav Seshadri, et al.. (2007). Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proceedings of the National Academy of Sciences. 104(36). 14501–14506. 335 indexed citations
9.
Banks, Charles A.S., Stephanie E. Kong, Henrik Spåhr, et al.. (2006). Identification and Characterization of a Schizosaccharomyces pombe RNA Polymerase II Elongation Factor with Similarity to the Metazoan Transcription Factor ELL. Journal of Biological Chemistry. 282(8). 5761–5769. 23 indexed citations
10.
Charlet‐Berguerand, Nicolas, Sascha Feuerhahn, Stephanie E. Kong, et al.. (2006). RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors. The EMBO Journal. 25(23). 5481–5491. 161 indexed citations
11.
Kong, Stephanie E., Charles A.S. Banks, Ali Shilatifard, Joan Conaway, & Ronald Conaway. (2005). ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proceedings of the National Academy of Sciences. 102(29). 10094–10098. 79 indexed citations
12.
Gerber, Mark A., Joel C. Eissenberg, Stephanie E. Kong, et al.. (2004). In Vivo Requirement of the RNA Polymerase II Elongation Factor Elongin A for Proper Gene Expression and Development. Molecular and Cellular Biology. 24(22). 9911–9919. 29 indexed citations
13.
Kong, Stephanie E., Michael S. Kobor, Nevan J. Krogan, et al.. (2004). Interaction of Fcp1 Phosphatase with Elongating RNA Polymerase II Holoenzyme, Enzymatic Mechanism of Action, and Genetic Interaction with Elongator. Journal of Biological Chemistry. 280(6). 4299–4306. 35 indexed citations
14.
Sato, Shigeo, Chieri Tomomori‐Sato, Charles A.S. Banks, et al.. (2003). Identification of Mammalian Mediator Subunits with Similarities to Yeast Mediator Subunits Srb5, Srb6, Med11, and Rox3. Journal of Biological Chemistry. 278(17). 15123–15127. 46 indexed citations
15.
Kong, Stephanie E., Ali Shilatifard, Ronald Conaway, & Joan Conaway. (2003). Preparation and Assay of RNA Polymerase II Elongation Factors Elongin and ELL. Methods in enzymology on CD-ROM/Methods in enzymology. 371. 276–283. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wesley Hung Breakdown of academic impact, for papers by Taichi Uetsuki Breakdown of academic impact, for papers by Vincent Ossipow Breakdown of academic impact, for papers by Juliet Reid Breakdown of academic impact, for papers by Carolyn H. Michnoff Breakdown of academic impact, for papers by Peri Tate Breakdown of academic impact, for papers by Akiko Yanagiya Breakdown of academic impact, for papers by Alison L. Clayton Breakdown of academic impact, for papers by Ira Schieren Breakdown of academic impact, for papers by Galit Shohat-Ophir
Rankless by CCL
2026